HIV蛋白酶抑制剂——利托那韦

戴罡 朱珠

中国药学杂志 ›› 2000, Vol. 35 ›› Issue (07) : 495-496.

中国药学杂志 ›› 2000, Vol. 35 ›› Issue (07) : 495-496.
国外新药

HIV蛋白酶抑制剂——利托那韦

  • 戴罡,朱珠
作者信息 +
文章历史 +

引用本文

导出引用
戴罡 朱珠. HIV蛋白酶抑制剂——利托那韦[J]. 中国药学杂志, 2000, 35(07): 495-496

参考文献

[1]Danner SA,Carr A,Leonard JM,et al.A short-term study of the safe-ty,pharmacokinetics,and efficacy of ritonavir,an inhibitor of HIV-1 protease[J].N Engl J Med,1995,333:1528. [2]Lal R,Hsu A,Chen p,et al.Single dose pharmacokinetics of ABT-378 in combination with ritonavir (abstract).37 th Intersci Conf Antimi-crob Agents Chemother (ICAAC),Toronto,September 28-October 1,1997:279. [3]Horneff G,Adams O,Wahn V.Preliminary experiences with ritonavir in children with advanced HIV infection[J].Infection,1999,27(2):103107. [4]Arribase JR,Ibanez C,Ruiz-Antoran B,et al.Acute hepatitis in HIV-infected patients during ritonavir treatment[J].AIDS,1998,12(13):1722. [5]Benveniste O,Longuet P,Duval X,et al.Two episodes of acute renal failure,rhabdomyolysis,and severe hepatitis in an AIDS patient succe-sively treated with ritonavir and indinavir[J].Clin Infect Dis,1999,28:1180. [6]Blanche P,Rigolet A,Gombert B,et al.Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir[J].Postgrad Med J,1999,75(887):546.

45

Accesses

0

Citation

Detail

段落导航
相关文章

/